University of Cambridge

University of Cambridge technology spin-out Zetta Genomics announces that has raised £2.5 million in new seed funding

Researchers from the University of Cambridge and European Molecular Biology Laboratory’s European Bioinformatics Institute (EMBL-EBI) have used a large-scale human genetics study to identify drug targets important for managing Covid-19 in its early stages.

The University of Cambridge is set to receive a new AI supercomputer as part of a £10 million partnership between the Engineering and Physical Sciences Research Council (EPSRC), the Science and Technology Facilities Council (STFC) and the University